RN2 Technologies Finalizes EGM Agenda, Proposes New Directors and Blockchain Business Expansion
RN2 Technologies will hold an extraordinary general meeting on July 10, 2026 to elect five new directors and amend its articles of incorporation.
Candidates include three inside directors: Jo Gyu-seong, Im Si-woong, and Yun Chang-don; and two outside directors: Song Jae-byeong and Lee Yong-pyo.
The amendment adds business purposes related to blockchain technology, digital assets, and virtual currency consulting to diversify operations.
No capital changes or dilution events are involved, limiting near-term impact on shareholder value.
[AI Summary]The new directors bring experience in medical AI, healthcare, and accounting, potentially creating synergies, but the addition of blockchain businesses carries execution risk. The stock price outlook remains neutral in the short term, with attention needed on long-term strategic direction.
KOSDAQ Filing Information
[Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)